Enthea
                                                                                                                                    
                                                                                                United States
                                                 -                                                 Boston
                                                                                            
                                                                                    - 19/12/2022
 - Seed
 - $2,000,000
 
Psychedelic Healthcare as a Workplace Benefit.  
Creating benefit plans for progressive, compassionate employers.
We are on a mission to expedite safe, affordable access to psychedelic-assisted therapy for all who can benefit.  
Supporting healing from within.
- Industry Insurance and Employee Benefit Funds
 - Website https://www.enthea.com/
 - LinkedIn https://www.linkedin.com/company/entheahealth/
 
Related People
Sherry R.Founder
                                                    
                                                                                                                Canada -
                                                         Toronto, Ontario
                                                    
                                                I have helped dozens of startups, non-profit organizations, academic/research institutions, and small businesses raise funds, operate according to their mission and values, and implement processes that enhance their efficiency. 
I believe in living and working in alignment with purpose and I am currently focused on expanding access to psychedelic-assisted therapy to alleviate human suffering. 
Before this, I consulted with the United Nations and World Bank for 10 years, implementing cash transfer programs at the national level in over 35 countries. 
I have a Master’s Degree in Public Policy and Management from the London School of Economics and a Bachelor’s Degree in Neuroscience and International Development from McGill University. I also completed the Certificate in Psychedelic Therapies and Research from CIIS in 2021. 
In addition to being Enthea's CEO, I am the Executive Director of the Boston Psychedelic Research Group, HR Consultant for Sensorium Therapeutics, and Strategic Advisor for CIIS. 
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                mimic(SWITZERLAND) |  $160,000,000  | (Nov 4, 2025)
                            
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                    
                                            
                                                
                                                    
                                                
                                                
                                                    
                                                
                                                
                                                
                                                
                                                
                                                    
                                                
                                                    
                                                
                                                    
                                                                        
                                Zeeg |  $1,265,935  | (Nov 4, 2025)
                            
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)
                                                                        
                                octonomy |  $20,000,000  | (Nov 4, 2025)
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                Hullbot |  $16,000,000  | (Nov 4, 2025)
                                                                        
                                Indomo |  $25,000,000  | (Nov 4, 2025)
                                                                        
                                AUI™ (Augmented Intelligence) |  $20,000,000  | (Nov 4, 2025)
                                                                        
                                Popai Health |  $11,000,000  | (Nov 4, 2025)